Supply and market disruption refers to coordinated strategies aimed at reducing the production, trafficking, distribution, and availability of illicit substances. These strategies often involve law enforcement, regulatory controls, border management, and financial investigations designed to disrupt drug trafficking networks and weaken illicit drug markets. By targeting supply chains and market dynamics, these efforts aim to reduce the availability of drugs, increase the risks and costs associated with illegal production and distribution, and contribute to broader efforts to reduce substance-related harms. Effective supply and market disruption typically operates alongside public health, prevention, treatment, and recovery responses as part of a comprehensive approach to substance use.
Supply & Market Disruption
2021 International Narcotics Control Strategy Report
2021 INCSR–Volume I: Drug and Chemical Control (As submitted to Congress) To read the full report, please visit: https://www.state.gov/2021-incsr-volume-i-drug-and-chemical-control-as-submitted-to-congress/
Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Sixth Session)
ISSUP Nigeria are pleased to present the next Webinar in their Bi-Monthly Knowledge Update Series. This Webinar focuses on 'The Role of Law Enforcement in Evidence-Based Substance Use Prevention'.
World Situation with Regard to Drug Trafficking
This report provides an overview of the latest trends in the illicit production of and trafficking in drugs worldwide. The statistics and analysis in the report are based on the latest information available to the United Nations Office on...
Measuring Organized Crime in the Western Balkans
Executive Summary The findings of this report are based on a statistical and analytical framework to measure and assess organized crime in the Western Balkans. Six countries and territories are included: Albania, Bosnia and Herzegovina...
The Effects of COVID-19 on the Illegal Drug Supply
This webinar explored how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy...
The Effects of COVID-19 on the Illegal Drug Supply
This webinar will explore how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy opportunities. Presentations will highlight different perspectives, including systems-level epidemiology data, findings from a local drug checking program and experiences shared by people who use drugs.
The Rapidly Changing Composition of the World's Drug Supply and Its Effects on High-Risk for COVID-19
The first of two presentations by Thom Browne Jr. covering illicit drugs and adulterants that place users at risk for COVID-19.
The Rapidly Changing Composition of the World's Drug Supply and Its Effects on High-Risk for COVID-19
The second of two presentations by Thom Browne Jr. covering illicit drugs and adulterants that place users at risk for COVID-19.
The Rapidly Changing Composition of the World's Drug Supply and Its Effects on High-Risk for COVID-19
The second of two presentations by Thom Browne Jr. (MA Criminal Justice, CEO of Colombo Plan) on the emerging and rapidly-changing properties of illicit drugs and their cutting agents that put substance users worldwide at high-risk for near- and long-term chronic health problems, overdose (fatal & non-fatal), and increased vulnerability to both the acquisition of viruses like COVID-19 and more severe complications from the virus.
The Rapidly Changing Composition of the World's Drug Supply and Its Effects on High-Risk for COVID-19
The first of two presentations by Thom Browne Jr. (MA Criminal Justice, CEO of Colombo Plan) on the emerging and rapidly-changing properties of illicit drugs and their cutting agents that put substance users worldwide at high-risk for near- and long-term chronic health problems, overdose (fatal & non-fatal), and increased vulnerability to both the acquisition of viruses like COVID-19 and more severe complications from the virus.